Skye Bioscience Common Stock Technical Analysis
| SKYE Stock | USD 0.72 0.06 7.69% |
As of the 11th of February 2026, Skye Bioscience has the Coefficient Of Variation of (657.68), variance of 37.78, and Risk Adjusted Performance of (0.11). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Skye Bioscience Common, as well as the relationship between them. Please validate Skye Bioscience Common market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Skye Bioscience is priced more or less accurately, providing market reflects its prevalent price of 0.72 per share. As Skye Bioscience Common is a penny stock we also advise to double-check its jensen alpha numbers.
Skye Bioscience Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Skye, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SkyeSkye Bioscience's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Skye Bioscience Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 8.25 | Strong Buy | 7 | Odds |
Most Skye analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Skye stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Skye Bioscience Common, talking to its executives and customers, or listening to Skye conference calls.
Will Biotechnology sector continue expanding? Could Skye diversify its offerings? Factors like these will boost the valuation of Skye Bioscience. If investors know Skye will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Skye Bioscience data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Skye Bioscience Common is measured differently than its book value, which is the value of Skye that is recorded on the company's balance sheet. Investors also form their own opinion of Skye Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Skye Bioscience's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Skye Bioscience's market value can be influenced by many factors that don't directly affect Skye Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Skye Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Skye Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Skye Bioscience's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Skye Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Skye Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Skye Bioscience.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Skye Bioscience on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Skye Bioscience Common or generate 0.0% return on investment in Skye Bioscience over 90 days. Skye Bioscience is related to or competes with Aligos Therapeutics, Xilio Development, INmune Bio, X4 Pharmaceuticals, Kezar Life, Barinthus Biotherapeutics, and PDS Biotechnology. Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules ... More
Skye Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Skye Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Skye Bioscience Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 25.49 | |||
| Value At Risk | (8.05) | |||
| Potential Upside | 10.19 |
Skye Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Skye Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Skye Bioscience's standard deviation. In reality, there are many statistical measures that can use Skye Bioscience historical prices to predict the future Skye Bioscience's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.02) | |||
| Total Risk Alpha | (1.58) | |||
| Treynor Ratio | (0.99) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Skye Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Skye Bioscience February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (0.98) | |||
| Mean Deviation | 4.8 | |||
| Coefficient Of Variation | (657.68) | |||
| Standard Deviation | 6.15 | |||
| Variance | 37.78 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (1.02) | |||
| Total Risk Alpha | (1.58) | |||
| Treynor Ratio | (0.99) | |||
| Maximum Drawdown | 25.49 | |||
| Value At Risk | (8.05) | |||
| Potential Upside | 10.19 | |||
| Skewness | 0.996 | |||
| Kurtosis | 0.9419 |
Skye Bioscience Common Backtested Returns
Skye Bioscience Common owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.14, which indicates the firm had a -0.14 % return per unit of risk over the last 3 months. Skye Bioscience Common exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Skye Bioscience's Risk Adjusted Performance of (0.11), variance of 37.78, and Coefficient Of Variation of (657.68) to confirm the risk estimate we provide. The entity has a beta of 0.96, which indicates possible diversification benefits within a given portfolio. Skye Bioscience returns are very sensitive to returns on the market. As the market goes up or down, Skye Bioscience is expected to follow. At this point, Skye Bioscience Common has a negative expected return of -0.88%. Please make sure to validate Skye Bioscience's jensen alpha, as well as the relationship between the skewness and day median price , to decide if Skye Bioscience Common performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.27 |
Poor predictability
Skye Bioscience Common has poor predictability. Overlapping area represents the amount of predictability between Skye Bioscience time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Skye Bioscience Common price movement. The serial correlation of 0.27 indicates that nearly 27.0% of current Skye Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.27 | |
| Spearman Rank Test | 0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Skye Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Skye Bioscience Common Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Skye Bioscience Common across different markets.
About Skye Bioscience Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Skye Bioscience Common on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Skye Bioscience Common based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Skye Bioscience Common price pattern first instead of the macroeconomic environment surrounding Skye Bioscience Common. By analyzing Skye Bioscience's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Skye Bioscience's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Skye Bioscience specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Interest Debt Per Share | 0.0449 | 0.0426 | Revenue Per Share | 8.94 | 9.39 |
Skye Bioscience February 11, 2026 Technical Indicators
Most technical analysis of Skye help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Skye from various momentum indicators to cycle indicators. When you analyze Skye charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (0.98) | |||
| Mean Deviation | 4.8 | |||
| Coefficient Of Variation | (657.68) | |||
| Standard Deviation | 6.15 | |||
| Variance | 37.78 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (1.02) | |||
| Total Risk Alpha | (1.58) | |||
| Treynor Ratio | (0.99) | |||
| Maximum Drawdown | 25.49 | |||
| Value At Risk | (8.05) | |||
| Potential Upside | 10.19 | |||
| Skewness | 0.996 | |||
| Kurtosis | 0.9419 |
Skye Bioscience February 11, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Skye stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 47,017 | ||
| Daily Balance Of Power | (0.67) | ||
| Rate Of Daily Change | 0.92 | ||
| Day Median Price | 0.76 | ||
| Day Typical Price | 0.74 | ||
| Price Action Indicator | (0.07) |
Complementary Tools for Skye Stock analysis
When running Skye Bioscience's price analysis, check to measure Skye Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Skye Bioscience is operating at the current time. Most of Skye Bioscience's value examination focuses on studying past and present price action to predict the probability of Skye Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Skye Bioscience's price. Additionally, you may evaluate how the addition of Skye Bioscience to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |